cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes

Journal of Clinical Investigation

Volumn 99, Issue 11, 1997, Pages 2710-2718

  Rivet Bastide, Michèle ^a,c   Vandecasteele, Grégoire ^a   Hatem, Stéphane ^a   Verde, Ignacio ^a   Bénardeau, Agnès ^a   Mercadier, Jean Jacques ^a   Fischmeister, Rodolphe ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSERM   (France)

^c UNIV LILLE   (France)

Author keywords

Adenosine deaminase; Calcium channel current; cGMP; cGMP stimulated phosphodiesterase; EHNA (Erythro 9 2 hydroxy 3 nonyl adenine; Human cardiac myocytes

Indexed keywords

9 (2 HYDROXY 3 NONYL)ADENINE; CALCIUM ION; CYCLIC GMP PHOSPHODIESTERASE; ISOPRENALINE; PENTOSTATIN; PHOSPHODIESTERASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; HEART ATRIUM; HEART DISEASE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030958762     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119460     Document Type: Article

References (48)

1. nd messenger systems. Prog. Biophys. Mol. Biol. 52: 165-247.
2. McDonald, T.F., S. Pelzer, W. Trautwein, and D.J. Pelzer. 1994. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol. Rev. 74:365-507.
3. Hove-Madsen, L., P.-F. Méry, J. Jurevicius, A.V. Skeberdis, and R. Fischmeister. 1996. Regulation of myocardial calcium channels by cyclic AMP metabolism. Basic Res. Cardiol. 91:1-8.
4. Beavo, J.A. 1995. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75:725-748.
5. Conti, M., G. Nemoz, C. Sette, and E. Vicini. 1995. Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocr. Rev. 16: 370-389.
6. Stoclet, J.-C., T. Keravis, N. Komas, and C. Lugnier. 1995. Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiovascular diseases. Exp. Opin. Invest. Drugs. 4:1081-1100.
7. m cyclic AMP phosphodiesterases in cardiac cells. Mol. Pharmacol. 38: 426-433.
8. Ono, K., and W. Trautwein. 1991, Potentiation by cyclic GMP of β-adrenergic effect on calcium current in guinea-pig ventricular cells. J. Physiol. (Lond.). 443:387-404.
9. Kirstein, M., M. Rivet-Bastide, S. Hatem, A. Benardeau, J.-J. Mercadier, and R. Fischmeister. 1995. Nitric oxide regulates the calcium current in isolated human atrial myocytes. J. Clin. Invest. 95:794-802.
10. Shirayama, T., and A.J. Pappano. 1996. Biphasic effects of intrapipette cyclic guanosine monophosphate on L-type calcium current and contraction of guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther. 279:1274-1281.
11. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. USA. 88:1197-1201.
12. 2+ current in single heart cells. Nature (Lond.). 323: 273-275.
13. Fischmeister, R., and H.C. Hartzell. 1987. Cyclic guanosine 3′,5′-monophosphate regulates the calcium current in single cells from frog ventricle. J. Physiol. (Lond.). 387:453-472.
14. 2+ current - involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J. Biol. Chem. 268:26286-26295.
15. 2+ channels by cGMP and NO. In Molecular Physiology and Pharmacology of Cardiac Ion Channels and Transporters. M. Morad, S. Ebashi, W. Trautwein, and Y. Kurachi, editors. Kluwer Academic Publishers Group, Dordrecht, The Netherlands/Boston/London. 93-105.
16. Méry, P.-F., C. Pavoine, F. Pecker, and R. Fischmeister. 1995. Erythro-9-[2-hydroxy-3-nonyl]adenine inhibits cGMP-stimulated phosphodiesterase in isolated cardiac myocytes. Mol. Pharmacol. 48:121-130.
17. Podzuweit, T., P. Nennstiel, and A. Müller. 1995. Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine. Cell. Signalling. 7:733-738.
18. Schaeffer, H.J., and C.F. Schwender. 1974. Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines. J. Med. Chem. 17:6-8.
19. Michie, A.M., M. Lobban, T. Muller, M. Harnett, and M.D. Houslay. 1996. Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram. Cell. Signalling. 8:97-110.
20. Suttorp, N., S. Hippenstiel, M. Fuhrmann, M. Krull, and T. Podzuweit. 1996. Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability. Am. J. Physiol. (Cell. Physiol.). 270:C778-C785.
21. Haynes, J., D.W. Killilea, P.D. Peterson, and W.J. Thompson. 1996. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3′,5′-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung. J. Pharmacol. Exp. Ther. 276:752-757.
22. Zhu Q., X. Tang, M.A. Claydon, G.L. Hicks, Jr., and T. Wang. 1994. Adenosine deaminase inhibitor in cardioplegia enhanced function preservation of the hypothermically stored rat heart. Transplantation (Baltimore). 57:35-40.
23. Xia, Y., G. Khatchikian, and J.L. Zweier. 1996. Adenosine deaminase inhibition prevents free radical-mediated injury in the postischemic heart. J. Biol. Chem. 271:10096-10102.
24. Perrella, M.A., T.R. Schwab, B. O'Murchu, M.M. Redfield, C-M. Wei, B.S. Edwards, and J.C. Burnett, Jr. 1992. Cardiac atrial natriuretic factor during evolution of congestive heart failure. Am. J. Physiol. 262:H1248-H1255.
25. De Belder, A., M.W. Radomski, H.J.F. Why, P.J. Richardson, CA. Bucknall, E. Salas, J.F. Martin, and S. Moncada. 1993. Nitric oxide synthase activities in human myocardium. Lancet (N. Am. Ed.). 341:84-85.
26. Winlaw, D.S., G.A. Smythe, A.M. Keogh, C.G. Schyvens, P.M. Spratt, and P.S. Macdonald. 1994. Increased nitric oxide production in heart failure. Lancet (N. Am. Ed.). 344:373-374.
27. Rücker-Martin, C., S. Hatem, J. Dubus, L. Mace, J.-L. Samuel, and J.-J. Mercadier. 1993. Behaviour of human atrial myocytes in culture is donor age-dependent. Neuromusc. Disord. 3:385-390.
28. Pucéat, M., O. Clément, P. Lechêne, J.M. Pelosin, R. Ventura-Clapier, and G. Vassort. 1990. Neurohormonal control of calcium sensitivity of myofilaments in rat single heart cells. Circ. Res. 67:517-524.
29. Hamill, O.P., A. Marty, E. Neher, B. Sakmann, and F.J. Sigworth. 1981. Improved patch-clamp techniques for high-resolution current recordings from cell and cell-free patches. Pflügers Arch. Eur. J. Physiol. 391:85-100.
30. Wagner, D.R., F. Bontemps, and G. Vandenberghe. 1994. Existence and role of substrate cycling between AMP and adenosine in isolated rabbit cardiomyocytes under control conditions and in ATP depletion. Circulation. 90:1143-1349.
31. Tremblay, J., R. Gerzer, and P. Hamet. 1988. Cyclic GMP in cell function. Adv. Sec. Messenger Prot. Phosphoryl. Res. 22:320-383.
32. Waldman, S.A., D.C. Leitman, and F. Murad. 1991. Immunoaffinity purification of soluble guanylyl cyclase. Methods Enzymol. 195:391-396.
33. + current in human atrial cells. Pflügers Arch. Eur. J. Physiol. 421: 486-491.
34. Gilman, A.G. 1987. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56:615-649.
35. Beavo, J.A., J.G. Hardmann, and E.W. Sutherland. 1971. Stimulation of adenosine 3′,5′ monophosphate hydrolysis by guanosine 3′,5′ monophosphate. J. Biol. Chem. 246:3841-3846.
36. Pelzmann, B., P. Schaffer, H. Mächler, B. Rigler, and B. Koidl. 1995. Adenosine inhibits the L-type calcium current in human atrial myocytes. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:293-297.
37. Schrader, W.P., and C.A. West. 1990. Localization of adenosine deaminase and adenosine deaminase complexing protein in rabbit heart. Implications for adenosine metabolism. Circ. Res. 66:754-762.
38. Penningroth, S.M. 1986. Erythro-9-[3-2(hydroxynonyl)]adenine and vanadate as probes for microtubule-based cytoskeletal mechanochemistry. Methods Emzymol. 134:477-483.
39. Schliwa, M., R.M. Ezzell, and U. Euteneuer. 1984. Erythro-9-[3-2(hydroxynonyl)]adenine is an effective inhibitor of cell motility and actin assembly Proc. Natl. Acad. Sci. USA. 81:6044-6048.
40. 2+ current regulation in cardiac cells. Life Sci. 48:2365-2376.
41. Levi, R.C., G. Alloatti, and R. Fischmeister. 1989. Cyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes. Pflügers Archiv. (Eur. J. Physiol.). 413:685-687.
42. Han, X., Y. Shimoni, and W.R. Giles. 1994. An obligatory role for nitric oxide in autonomie control of mammalian heart rate. J. Physiol. (Lond.). 476-309-314.
43. Han, X., Y. Shimoni, and W.R. Giles. 1995. A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate. J. Gen. Physiol. 106:45-65.
44. Balligand, J.-L., L. Kobzik, X.Q. Han, D.M. Kaye, L. Belhassen, D.S. Ohara, R.A. Kelly, and T.W. Smith. 1995. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J. Biol. Chem. 270:14582-14586.
45. 2+ current in adult rabbit atrioventricular nodal cells. Circ. Res. 78:998-1008.
46. Zakharov, S.I., S. Pieramici, G.K. Kumar, N.R. Prabhakar, and R.D. Harvey. 1996. Nitric oxide synthase activity in guinea pig ventricular myocytes is not involved in muscarinic inhibition of cAMP-regulated ion channels. Circ. Res. 78:925-935.
47. 2+ current by acting exclusively at a site proximal to adenylyl cyclase in frog cardiac myocytes. J. Physiol. (Lond.). 491:669-675.
48. Méry, P.F., L. Hove-Madsen, J.-M. Chesnais, H.C. Hartzell, and R. Fischmeister. 1996. Nitric oxide synthase does not participate in the negative inotropic effect of acetylcholine in frog heart. Am. J. Physiol. (Heart Circ. Physiol.). 39:H1178-H1188.